Beranda › Kanker Kolorektal › Washington › Seattle
Uji klinis Kanker Kolorektal di Seattle, WA
34 studi untuk Kanker Kolorektal mencari peserta di lokasi sekitar Seattle (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
Menerima pesertaFase 3
- University Of Washington-Fred Hutchinson Cancer Center - Seattle /ID# 281451, Seattle
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Menerima pesertaFase 1/2
- University of Washington, Fred Hutchinson Cancer Center, Seattle
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- dan 1 lainnya
Family Communications After Genetic Testing
Menerima pesertaSukarelawan sehat diterima
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- dan 1 lainnya
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Menerima pesertaFase 1
- Fred Hutchinson Cancer Center, Seattle
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Menerima pesertaFase 1/2
- Fred Hutchinson Cancer Research Center, Seattle
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
Menerima pesertaFase 2
- Virginia Mason Medical Center, Seattle
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
Menerima pesertaFase 2
- University Of Washington-Fred Hutchinson Cancer Center - Seattle /ID# 271298, Seattle
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Menerima pesertaFase 3
- Swedish Cancer Institute, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center, Seattle
- dan 1 lainnya
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Menerima pesertaStudi observasional
- Fred Hutchinson Cancer Center, Seattle
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
Menerima pesertaFase 1
- Swedish Cancer Institute, Seattle
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Menerima pesertaFase 3
- Fred Hutchinson Cancer Research Center, Seattle
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Menerima pesertaFase 3
- Swedish Cancer Institute, Seattle
- Fred Hutchinson Cancer Research Center, Seattle
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Menerima pesertaFase 2/3
- Local Institution - 0253, Seattle
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Menerima pesertaFase 1/2
- Fred Hutchinson Cancer Center, Seattle
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Menerima pesertaFase 1/2
- Fred Hutchinson Cancer Research Center, Seattle
Improving Uptake of Surveillance in Colorectal Cancer Survivors Through Navigation and Web Education
Menerima peserta
- Benaroya Research Institute at Virginia Mason, Seattle
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
Menerima pesertaFase 2
- Swedish Cancer Institute, Seattle
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Menerima pesertaFase 1
- Fred Hutchinson Cancer Center, Seattle
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
Menerima pesertaStudi observasional
- University of Washington, Seattle
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
Menerima pesertaFase 1
- Fred Hutchinson Cancer Center, Seattle
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Menerima pesertaFase 1
- University Of Washington, Seattle
A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With Abnormal Fecal Immunochemical Test Results, PROACT Trial
Menerima pesertaSukarelawan sehat diterima
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Menerima pesertaFase 1/2
- Fred Hutchinson Cancer Center, Seattle
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Menerima pesertaFase 1
- Fred Hutchinson Cancer Center, Seattle
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Menerima pesertaFase 1/2
- Virginia Mason Medical Center, Seattle
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Menerima pesertaFase 1/2
- Virginia Mason Medical Center, Seattle
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Menerima pesertaFase 3Sukarelawan sehat diterima
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- dan 1 lainnya
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Menerima pesertaFase 1/2
- Fred Hutchinson Cancer Center, Seattle
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Menerima pesertaStudi observasional
- Kaiser Permanente Washington, Seattle
- Swedish Medical Center-First Hill, Seattle
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Menerima pesertaFase 1/2
- Fred Hutch Cancer Center, Seattle
ColoCare Study - Colorectal Cancer Cohort
Menerima pesertaStudi observasional
- FHCRC, Seattle
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Menerima pesertaStudi observasional
- University of Washington / Fred Hutchinson Cancer Center, Seattle
A Study of IBI363 in Subjects with Advanced Solid Malignancies
Menerima pesertaFase 2
- Fred Hutchinson Cancer Center, Seattle
Uji klinis Kanker Kolorektal di kota lain
- Houston, TX102 studi
- New York City, NY77 studi
- Nashville, TN69 studi
- Boston, MA63 studi
- Los Angeles, CA59 studi
- Arlington, VA52 studi
- St. Louis, MO50 studi
- San Antonio, TX46 studi
- Philadelphia, PA44 studi
- Grand Rapids, MI40 studi
- Baldwin Park, CA38 studi
- Tampa, FL33 studi
Studi lain di Seattle
- Kanker Paru Non-Sel Kecil53 studi
- Kanker (semua jenis)49 studi
- Kanker Prostat42 studi
- Leukemia Mieloid Akut40 studi
- Kanker Payudara39 studi
- Kanker Metastatik39 studi
- Kanker Paru33 studi
- Kanker Ovarium30 studi
- Mieloma Multipel22 studi
- Sindrom Mielodisplastik21 studi
- Leukemia Limfoblastik Akut21 studi
- Kanker Kandung Kemih21 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.